A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia
Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
This study will assess the efficacy and safety of intravenous beta-lactam, in comparison with
ceftriaxone, in hospitalized patients with community-acquired pneumonia not caused by
Legionella. The anticipated time on study treatment is 3-12 months and the target sample size
is 100-500 individuals.